x
ServiziMenu principaleHome
Facebook Twitter Linkedin Print
Home > News > Adjuvant Pertuzumab and Trastuzumab in EarlyHuman Epidermal Growth Factor Receptor 2-PositiveBreast Cancer in the APHINITY Trial: Third InterimOverall

Adjuvant Pertuzumab and Trastuzumab in EarlyHuman Epidermal Growth Factor Receptor 2-PositiveBreast Cancer in the APHINITY Trial: Third InterimOverall Survival Analysis With Efficacy Update

Scarica il documento in PDF

Apri